Updates in the Treatment of Newly Diagnosed Multiple Myeloma from ASH 2023 : Episode 6

Navigating High-Risk Disease in Multiple Myeloma: Treatment Strategies and the Role of ASCT

January 19, 2024

By Luciano Costa, MD, PhD
Philippe Moreau, MD

Opinion

Video

Experts dive into the complexities of defining and treating high-risk Multiple Myeloma (MM) and discuss the role of ASCT in newly diagnosed MM and weigh the considerations for recommending transplants, including insights on the selection criteria for tandem transplantations.

EP: 1.PERSEUS: Daratumumab plus VRd in Newly Diagnosed Multiple Myeloma Patients

EP: 2.Defining Success in Multiple Myeloma Induction and Maintenance

EP: 3.IsKia: Isatuximab Plus KRd in Pre-Transplant Induction and Post-Transplant Consolidation in TE NDMM

EP: 4.Role of MRD Negativity Rates in Treatment Decision Making

EP: 5.IFM 2018-04: Dara-KRd Induction and Consolidation Plus Double Transplant in HR TE NDMM

Now Viewing

EP: 6.Navigating High-Risk Disease in Multiple Myeloma: Treatment Strategies and the Role of ASCT

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Subscribe Now!